NDRG2 has been reported to suppress tumor progression through the regulation of NF-κB signaling20, 21; however, the detailed molecular mechanism by which NDRG2 regulates the canonical and/or non-canonical NF-κB pathways remains unclear. The gene discussed is NFKB1; the disease is neoplasm.